Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameDingdang Health
Stock Code09886
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities作為中國提供數字醫療健康到家服務的服務提供商,提供即時藥品零售、在線診療及慢病與健康管理,通過線上平台、線下智慧藥房及快藥服務運營。
Listing Date2022-09-14
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國 北京市 東城區 燈市口大街 50號院1號樓
Business Address (Hong Kong)香港 中環 皇后大道中99號中環中心 35樓3512單元
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.ddjkjt.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 12.00 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 6,000
Par ValueTo be extracted
Offer Period2022-09-01 to 2022-09-06
Global Offering Shares33,537,000 shares
HK Public Offer Shares (Initial)3,354,000 shares (10.0%)
Public Offer Lots (Initial)6,708lots (Pool A3,354lots,Pool B3,354lots)
International Placing Shares (Initial)30,183,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,341,472,897 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share74.1%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 402,444,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 6,000
2 lots 1,000 HK$ 12,000
3 lots 1,500 HK$ 18,000
4 lots 2,000 HK$ 24,000
5 lots 2,500 HK$ 30,000
6 lots 3,000 HK$ 36,000
7 lots 3,500 HK$ 42,000
8 lots 4,000 HK$ 48,000
9 lots 4,500 HK$ 54,000
10 lots 5,000 HK$ 60,000
12 lots 6,000 HK$ 72,000
14 lots 7,000 HK$ 84,000
16 lots 8,000 HK$ 96,000
18 lots 9,000 HK$ 108,000
20 lots 10,000 HK$ 120,000
30 lots 15,000 HK$ 180,000
40 lots 20,000 HK$ 240,000
50 lots 25,000 HK$ 300,000
60 lots 30,000 HK$ 360,000
70 lots 35,000 HK$ 420,000
80 lots 40,000 HK$ 480,000
90 lots 45,000 HK$ 540,000
100 lots 50,000 HK$ 600,000
120 lots 60,000 HK$ 720,000
140 lots 70,000 HK$ 840,000
160 lots 80,000 HK$ 960,000
180 lots 90,000 HK$ 1,080,000
200 lots 100,000 HK$ 1,200,000
400 lots 200,000 HK$ 2,400,000
800 lots 400,000 HK$ 4,800,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,000 lots 500,000 HK$ 6,000,000
2,000 lots 1,000,000 HK$ 12,000,000
3,354 lots 1,677,000 HK$ 20,124,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 1.08B
Est. Threshold HK$ 9.39B
Analysis Result HK market cap below threshold, need +767%

Valuation & Financials

Market Cap (at Offer Price)HK$ 16,097,674,764
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status虧損人民幣1,598.97百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201920202021
Revenue 1,275,5892,228,5633,678,690
Cost of sales -805,635-1,462,370-2,516,379
Gross profit 469,954766,1931,162,311
Other income and gains, net 5,14516,23015,905
Selling and distribution expenses -278,464-441,310-834,783
Administrative expenses -57,900-120,968-481,256
Net finance costs -5,571-6,061-17,776
Share of associates and JVs -91-2560
Profit before tax -265,696-900,887-1,581,859
Income tax expense -8,236-18,793-17,115
Profit for the year -273,932-919,680-1,598,974
Profit attributable to owners -276,635-924,250-1,578,026
Balance Sheet
Item 201920202021
Cash and cash equivalents 144,691260,5741,552,994
Trade and bills receivables 87,932187,584279,591
Inventories 168,549323,470434,022
Total current assets 445,2531,093,4172,267,693
Total assets 754,1771,786,1462,946,159
Total current liabilities 332,224601,505738,929
Total liabilities 1,191,5873,091,1885,535,988
Total equity -437,410-1,305,042-2,589,829
Equity attributable to owners -447,062-1,358,415-2,612,247
Cash Flow Statement
Item 2018201920202021-0320212022-03
Net cash from operating activities -265,897-193,046-295,490
Depreciation of PP&E 12,96216,78220,8795,42521,6505,146
Depreciation of right-of-use assets 19,56135,59347,74215,88778,40419,083
Amortisation of intangible assets 5905,1086,2578,78535,2328,825
Purchase of PP&E -10,540-20,276-19,595-3,840-20,466-5,756
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 12.0
First Day OpenHK$ 12.34
First Day Change-91.67%
First Day Volume4346000.0
First Day Turnover52933400.0
Use of Proceeds
1、約45.0%或約153.7百萬港元預期將用于業務擴張; 2、約15.0%或約51.2百萬港元用于優化我們的技術系統及運營平臺; 3、約10.0%或約34.2百萬港元用于提升我們的服務及業務; 4、約20.0%或約68.3百萬港元用于對我們經營的醫療產業價值鏈進行的潛在投資及收購或戰略合作; 5、約10.0%或約34.2百萬港元用于營運資金及其他一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 招银国际融资有限公司 CE AVM940
Overall Coordinators (2)
中国国际金融香港证券有限公司 CE AEN894 招银国际融资有限公司 CE AVM940
Joint Bookrunners (3)
中国国际金融香港证券有限公司 CE AEN894 招银国际融资有限公司 CE AVM940 富途证券国际(香港)有限公司 CE AZT137
Joint Lead Managers (4)
中国国际金融香港证券有限公司 CE AEN894 招银国际融资有限公司 CE AVM940 富途证券国际(香港)有限公司 CE AZT137 SILVERBRICKS SECURITIES COMPANY LIMITED CE BLN458

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Harvest International Premium Value (Secondary Market) Fund SPC 78,462,000 HKD — 19.50% — 6 months 2023-03-14
2 Jumpcan International Co., Ltd. 23,538,000 HKD — 5.85% — 6 months 2023-03-14
3 阳光人寿保险股份有限公司 196,158,000 HKD — 48.74% — 6 months 2023-03-14

Directors & Management

PositionChinese nameEnglish Name
Chairman楊文龍—
Company Secretary王永智、林曉波—
No director data available.

Major Shareholders

Major Shareholders & Holdings控股股東集團(楊文龍先生、楊益斌先生、楊瀟先生及相關公司)緊隨全球發售完成後(假設超額配股權未獲行使)合共持有約49.21%已發行股份;其他主要股東包括招銀金融控股(深圳)有限公司(7.10%)及TPG Asia VII(6.18%)。
About this page

This page shows Dingdang Health (09886) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect